Hydrophilic Fluorescent Nanoprodrug of Paclitaxel for Glioblastoma Chemotherapy-Reference-Cited by-同舟云学术

Hydrophilic Fluorescent Nanoprodrug of Paclitaxel for Glioblastoma Chemotherapy

Published:2019-10-24 Issue:19 Volume:4 Page:18342-18354
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Daniel Jonathan¹,Montaleytang Maeva²³,Nagarajan Sounderya²^ORCID,Picard Sébastien¹,Clermont Guillaume¹,Lazar Adina N.¹,Dumas Noé²^ORCID,Correard Florian²³,Braguer Diane²³,Blanchard-Desce Mireille¹^ORCID,Estève Marie-Anne²³^ORCID,Vaultier Michel¹

Affiliation:

1. Univ. Bordeaux, Institut des Sciences Moléculaires (CNRS UMR 5255), Bâtiment A12, 351 Cours de la Libération, 33405 Talence Cedex, France

2. Aix Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Faculté de Pharmacie, 27 Boulevard Jean Moulin - CS 30064, 13385 Marseille Cedex 05, Marseille, France

3. AP-HM, Hôpital Timone, 264 Rue Saint Pierre, 13385 Marseille Cedex 05, France

Funder

Agence Nationale de la Recherche

Institut National Du Cancer

Cancerop?le PACA

L?Institut Th?matique Multi-Organisme Cancer d'Aviesan

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.acs.org/doi/pdf/10.1021/acsomega.9b02588